Published in Diabetes Res on December 01, 1988
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol (2010) 6.64
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A (2006) 5.41
Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci (2008) 2.99
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat (2007) 2.58
Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia (2010) 2.21
Immunological complications of obesity. Nat Immunol (2012) 2.09
Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab (2008) 1.95
Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest (2003) 1.83
The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia (2009) 1.83
The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death. J Biol Chem (2011) 1.72
Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One (2010) 1.68
The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry (2010) 1.63
Beta-cell failure as a complication of diabetes. Rev Endocr Metab Disord (2008) 1.60
β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol (2011) 1.59
Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia (2011) 1.56
Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia (2009) 1.55
Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia (2009) 1.46
Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci U S A (2009) 1.45
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A (2010) 1.45
Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance. PLoS Biol (2008) 1.40
Quantification of pancreatic islet distribution in situ in mice. Am J Physiol Endocrinol Metab (2009) 1.40
Apoptosis of insulin-secreting cells induced by endoplasmic reticulum stress is amplified by overexpression of group VIA calcium-independent phospholipase A2 (iPLA2 beta) and suppressed by inhibition of iPLA2 beta. Biochemistry (2004) 1.36
Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus. Exp Diabetes Res (2011) 1.25
No mantle formation in rodent islets -- the prototype of islet revisited. Diabetes Res Clin Pract (2009) 1.22
Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets. Diabetologia (2008) 1.22
Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes. PLoS One (2011) 1.21
The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors. Biochemistry (2010) 1.21
The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase. Biochemistry (2007) 1.20
Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells. Diabetes (2010) 1.15
Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry (2012) 1.13
Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1994) 1.13
Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes. PLoS One (2013) 1.13
The proapoptotic BH3-only proteins Bim and Puma are downstream of endoplasmic reticulum and mitochondrial oxidative stress in pancreatic islets in response to glucotoxicity. Cell Death Dis (2014) 1.12
SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol (2010) 1.11
Inflammasome activation in obesity-related inflammatory diseases and autoimmunity. Discov Med (2011) 1.08
Amyloidogenesis of natively unfolded proteins. Curr Alzheimer Res (2008) 1.08
Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity. FEBS Lett (2013) 1.08
Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes. Diabetes (2011) 1.07
Islet amyloid polypeptide toxicity and membrane interactions. Proc Natl Acad Sci U S A (2013) 1.06
Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells. Am J Pathol (1999) 1.06
Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers. Protein Sci (2012) 1.05
Glucose- and time-dependence of islet amyloid formation in vitro. Biochem Biophys Res Commun (2007) 1.05
Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets. Diabetologia (2011) 1.05
Revascularization of transplanted pancreatic islets and role of the transplantation site. Clin Dev Immunol (2013) 1.04
Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology. Curr Opin Struct Biol (2012) 1.04
Deamidation accelerates amyloid formation and alters amylin fiber structure. J Am Chem Soc (2012) 1.03
Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress. Diabetologia (2009) 1.02
Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass. Am J Physiol Endocrinol Metab (2011) 1.01
Pancreatic beta cells lack a low glucose and O2-inducible mitochondrial protein that augments cell survival. Proc Natl Acad Sci U S A (2006) 1.01
The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation. J Mol Biol (2010) 1.00
Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20. J Mol Biol (2011) 1.00
Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus. Am J Pathol (1998) 0.99
Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro. Am J Physiol Cell Physiol (2007) 0.97
Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains. Int J Exp Pathol (2010) 0.93
The effect of type-2-diabetes-related vascular endothelial dysfunction on skin physiology and activities of daily living. J Diabetes Sci Technol (2011) 0.93
Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture. Diabetes (2008) 0.93
Alpha-, Delta- and PP-cells: Are They the Architectural Cornerstones of Islet Structure and Co-ordination? J Histochem Cytochem (2015) 0.91
Type 2 diabetes as a protein misfolding disease. Trends Mol Med (2015) 0.91
Impact of obesity severity and duration on pancreatic β- and α-cell dynamics in normoglycemic non-human primates. Int J Obes (Lond) (2012) 0.91
Human Islets Have Fewer Blood Vessels than Mouse Islets and the Density of Islet Vascular Structures Is Increased in Type 2 Diabetes. J Histochem Cytochem (2015) 0.90
Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes. Exp Diabetes Res (2008) 0.88
One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice. Am J Physiol Endocrinol Metab (2013) 0.88
Amyloid in the islets of Langerhans: thoughts and some historical aspects. Ups J Med Sci (2011) 0.87
Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice. Am J Pathol (1991) 0.86
A link between endoplasmic reticulum stress-induced β-cell apoptosis and the group VIA Ca2+-independent phospholipase A2 (iPLA2β). Diabetes Obes Metab (2010) 0.86
Cleavage agents for soluble oligomers of human islet amyloid polypeptide. J Biol Inorg Chem (2008) 0.86
Real-time monitoring of apoptosis by caspase-3-like protease induced FRET reduction triggered by amyloid aggregation. Exp Diabetes Res (2008) 0.85
Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates. J Mol Biol (2010) 0.84
CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients. BMC Pharmacol Toxicol (2014) 0.83
Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes. Endocrine (2015) 0.83
Effect of proline mutations on the monomer conformations of amylin. Biophys J (2013) 0.83
Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients. Amyloid (2014) 0.82
Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide. J Biol Chem (2012) 0.82
Glucagon secretion from pancreatic α-cells. Ups J Med Sci (2016) 0.81
Glucose-responsive beta cells in islets isolated from a patient with long-standing type 1 diabetes mellitus. Diabetologia (2010) 0.81
A simple matter of life and death-the trials of postnatal Beta-cell mass regulation. Int J Endocrinol (2012) 0.81
Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model. Endocrinology (2012) 0.81
Annexin A5 directly interacts with amyloidogenic proteins and reduces their toxicity. Biochemistry (2009) 0.81
Degradation of islet amyloid polypeptide by neprilysin. Diabetologia (2012) 0.81
Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization. Chem Commun (Camb) (2013) 0.81
Pancreas++: automated quantification of pancreatic islet cells in microscopy images. Front Physiol (2013) 0.80
Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic β-cell survival and function via CREB. J Nutr Biochem (2012) 0.80
Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes? J Histochem Cytochem (2015) 0.80
Membrane permeation induced by aggregates of human islet amyloid polypeptides. Biophys J (2013) 0.80
Increased ectodomain shedding of cell adhesion molecule 1 from pancreatic islets in type 2 diabetic pancreata: correlation with hemoglobin A1c levels. PLoS One (2014) 0.80
General amyloid inhibitors? A critical examination of the inhibition of IAPP amyloid formation by inositol stereoisomers. PLoS One (2014) 0.79
The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans. Biochemistry (2014) 0.79
Linking metabolic abnormalities to apoptotic pathways in Beta cells in type 2 diabetes. Cells (2013) 0.78
Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes. Mcgill J Med (2009) 0.78
Overall sulfation of heparan sulfate from pancreatic islet β-TC3 cells increases maximal fibril formation but does not determine binding to the amyloidogenic peptide islet amyloid polypeptide. J Biol Chem (2012) 0.78
Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects. Islets (2012) 0.78
Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients. Virchows Arch (2005) 0.77
Pathologic changes and glucose homeostasis according to expression of human islet amyloid polypeptide in type 2 diabetic patients. J Histochem Cytochem (2010) 0.77
Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus. Exp Diabetes Res (2008) 0.77
Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions. J Mol Biol (2012) 0.77
The Role of Immunogenicity in Cardiovascular Disease. World Heart J (2011) 0.77
The Role of Cholesterol in Driving IAPP-Membrane Interactions. Biophys J (2016) 0.77
Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas). Diabetologia (2015) 0.77
Analysis of the Ability of Pramlintide To Inhibit Amyloid Formation by Human Islet Amyloid Polypeptide Reveals a Balance between Optimal Recognition and Reduced Amyloidogenicity. Biochemistry (2015) 0.77
Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition. Biochemistry (2017) 0.77
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Publication bias in clinical research. Lancet (1991) 22.85
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia (2012) 10.74
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (2000) 10.66
Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care (1998) 8.29
Metformin. N Engl J Med (1996) 7.66
A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) (1972) 7.64
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ (1998) 7.48
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78
Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England. Br Med J (1980) 4.28
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med (2005) 3.80
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
The assessment of insulin resistance in man. Diabet Med (2002) 3.35
Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med (1983) 3.07
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia (2004) 3.01
Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors. Arch Intern Med (1992) 2.95
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol (1998) 2.93
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med (1999) 2.75
In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70
Linkage of type 2 diabetes to the glucokinase gene. Lancet (1992) 2.64
Student views on continuous assessment at Birmingham University Medical School. Br Med J (1975) 2.63
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia (2012) 2.53
The preregistration year: Chaos by consensus. Lancet (1977) 2.50
A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc Natl Acad Sci U S A (1999) 2.48
Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med (1988) 2.43
Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at -20 degrees C. Clin Chem (1992) 2.41
Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ (2000) 2.40
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia (2006) 2.37
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet (1973) 2.36
Recent advances in the monitoring and management of diabetic ketoacidosis. QJM (2004) 2.33
Fatigue testing median sternotomy closures. Eur J Cardiothorac Surg (2001) 2.27
Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med (2008) 2.26
Polymorphic fibrillar assembly of human amylin. J Struct Biol (1997) 2.26
Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med (1979) 2.25
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Obes Metab (2009) 2.23
Home blood sampling for plasma glucose assay in control of diabetes. Br Med J (1978) 2.22
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med (1998) 2.20
Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group. Diabet Med (2000) 2.20
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia (2009) 2.16
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15
Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism (1979) 2.07
Similarity of blood pressure in blacks, whites and Asians in England: the Birmingham Factory Study. J Hypertens (1985) 2.03
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97
Amyloid fibril formation from full-length and fragments of amylin. J Struct Biol (2000) 1.95
Casualties from terrorist bombings. J Trauma (1983) 1.95
One-stop diagnosis for symptomatic breast disease. Ann R Coll Surg Engl (1995) 1.94
Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J (1980) 1.94
Hypoglycaemia in African children with severe malaria. Lancet (1987) 1.88
Experimental experience with a temporary intraluminal heparin-bonded polyurethane arterial shunt. Br J Surg (1994) 1.86
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia (2012) 1.83
Watching amyloid fibrils grow by time-lapse atomic force microscopy. J Mol Biol (1999) 1.82
Can residents be trained to counsel patients about quitting smoking? Results from a randomized trial. J Gen Intern Med (1991) 1.81
Fate of research studies. J R Soc Med (1992) 1.79
Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab (2001) 1.78
The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer (1984) 1.77
A practical guide to basal and prandial insulin therapy. Diabet Med (1985) 1.76
Diabetes: The quest for basal normoglycaemia. Lancet (1977) 1.75
Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group. Int J Cancer (1979) 1.75
Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature (1988) 1.72
Approach to maintaining comparability of biochemical data during long-term clinical trials. Clin Chem (1997) 1.70
Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. QJM (2000) 1.68
Field surgery on a future conventional battlefield: strategy and wound management. Ann R Coll Surg Engl (1991) 1.64
Predictive markers in breast cancer--the present. Histopathology (2008) 1.62